Top Clinical Trials companies in Taiwan by Cash and Short-Term Investments

This ranking features the top 7 Clinical Trials companies in Taiwan ranked by Cash and Short-Term Investments, totaling a Cash and Short-Term Investments of USD 758.58 M, for February 04, 2025.
#
Name
Cash and Short-Term Investments
Reported Date
Stock Price
Change
Price (30 days) Country
1
USD 253.20 M
Dec. 31, 2023 USD 2.34 NA

Taiwan

2
USD 122.39 M
Dec. 31, 2023 USD 1.58 NA

Taiwan

3
USD 119.23 M
Dec. 31, 2023 USD 0.97 NA

Taiwan

4
USD 118.18 M
Dec. 31, 2023 USD 3.03 NA

Taiwan

5
USD 90.63 M
Dec. 31, 2023 USD 1.81 NA

Taiwan

6
USD 33.81 M
Dec. 31, 2023 USD 0.34 NA

Taiwan

7
USD 21.14 M
Dec. 31, 2023 USD 2.60 NA

Taiwan

Frequently Asked Questions
  • Which Clinical Trials company in Taiwan has the highest Cash and Short-Term Investments ?

    The Clinical Trials company in Taiwan with the highest Cash and Short-Term Investments is Oneness Biotech Co., Ltd. (Taipei Exchange: 4743.TWO) at USD 253.20 M.

  • Which Clinical Trials company in Taiwan has the lowest Cash and Short-Term Investments ?

    The Clinical Trials company in Taiwan with the lowest Cash and Short-Term Investments is TaiMed Biologics Inc. (Taipei Exchange: 4147.TWO) at USD 21.14 M.

SV Wall Street